News. Analysis. Insight.™ - 100 Years of Journalistic Excellence

•

Advanced Life Sciences Holdings, Inc. Add to My Watchlist

(OTCBB: ADLS)

0.22

-0.01 (-2.22%)

251,400

Advanced Life Sciences Holdings, Inc.
1440 Davey Road
Woodridge, IL 60517
http://www.advancedlifesciences.com

Advanced Life Sciences Holdings is a biopharmaceutical company focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, oncology and inflammation. Using its internal discovery capabilities and network of pharmaceutical and academic partners, Co. has assembled a pipeline of clinical and preclinical product candidates. Co.'s key product candidate, cethromycin, is a second-generation ketolide antibiotic in Phase III clinical development for the treatment of respiratory tract infections. Co. also has product candidates in earlier stages of development for the treatment of inflammation-related tissue damage and malignant melanoma.

Industry	Biotechnology
Sector	Healthcare
# of Employees	28
Shares Outstanding	78.1M
Market Cap	17.2M
Enterprise Value	-

52-Week High	$1.62
52-Week Low	$0.14
P/E Ratio	-0.42
EPS	-$0.53/shr
Dividend	-
Yield	-

Patrick W. Flavin

Chief Legal Couns.

Michael T. Flavin Ph.D.

Chmn., C.E.O.

R. Richard Wieland II

Exec. V.P., C.F.O.

Ze-Qi Xu Ph.D.

Exec. V.P., Chief Scientific Officer

Suseelan Pookote Ph.D.

Exec. V.P., Corp. Devel.

John L. Flavin

Pres.

David A. Eiznhamer Ph.D.

V.P., Biological Sciences

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Real Time Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs